Puma Biotech. beats by $0.34, misses on revs
- Reports Q1 (Mar) earnings of $0.03 per share, $0.34 better than the single analyst estimate of ($0.31).
- For the first quarter of 2018, total revenue was $66.5 million, of which $36.0 million was net product revenue and $30.5 million was license revenue received from Puma's sub-licensees.
No comments:
Post a Comment